Isolation and characterization of dominant and recessive IL-3-independent hematopoietic transformants

Oncogene

Volumn 25, Issue 50, 2006, Pages 6595-6603

  Kiser, K F ^a   Colombi, M ^a   Moroni, C ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

ICR191; Mast cells; Mutagenesis; Raf 1; Stat

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 6 CHLORO 9 [3 (2 CHLOROETHYL)AMINOPROPYLAMINO] 2 METHOXYACRIDINE; INTERLEUKIN 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAF PROTEIN; RAS PROTEIN; SORAFENIB; STAT5 PROTEIN;

ANIMAL CELL; ARTICLE; CELL FUSION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG INHIBITION; ENHANCER REGION; ENZYME ACTIVATION; FRAMESHIFT MUTATION; GENE INSERTION; MAST CELL; MOLECULAR CLONING; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETROVIRUS; VIRUS DNA CELL DNA INTERACTION;

AMINACRINE; BENZENESULFONATES; BUTADIENES; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; FRAMESHIFT MUTATION; GENES, DOMINANT; GENES, RECESSIVE; HEMATOPOIESIS; HUMANS; INTERLEUKIN-3; MAP KINASE KINASE KINASES; MUTAGENESIS, INSERTIONAL; NITRILES; NITROGEN MUSTARD COMPOUNDS; PROTO-ONCOGENE PROTEINS C-RAF; PYRIDINES; RETROVIRIDAE; STAT5 TRANSCRIPTION FACTOR; TRANSFECTION; TUMOR STEM CELLS;

EID: 33750491969     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209673     Document Type: Article

References (38)

1. Algate PA, McCubrey JA. (1993). Oncogene 8: 1221-1232.
2. Andrejauskas E, Moroni C. (1989). EMBO J 8: 2575-2581.
3. Benjamin D, Colombi M, Moroni C. (2004). Nucleic acids research 32: e89.
4. Blalock WL, Pearce M, Steelman LS, Franklin RA, McCarthy SA, Cherwinski H et al. (2000). Oncogene 19: 526-536.
5. Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA et al. (1999). Leukemia 13: 1109-1166.
6. D'Andrea R, Rayner J, Moretti P, Lopez A, Goodall GJ, Gonda TJ et al. (1994). Blood 83: 2802-2808.
7. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S et al. (1996). Nat Med 2: 561-566.
8. Gough NM. (1988). Analytical biochemistry 173: 93-95.
9. Hannemann J, Hara T, Kawai M, Miyajima A, Ostertag W, Stocking C. (1995). Mol Cell Biol 15: 2402-2412.
10. Hayakawa F, Towatari M, Kiyoi H, Tanimoto M, Kitamura T, Saito H et al. (2000). Oncogene 19: 624-631.
11. Hirsch HH, Nair AP, Moroni C. (1993). J Exp Med 178: 403-411.
12. Hoyle PE, Moye PW, Steelman LS, Blalock WL, Franklin RA, Pearce M et al. (2000). Leukemia 14: 642-656.
13. Ihle JN, Lee JC, Rebar L. (1981). J Immunol 127: 2565-2570.
14. Jiang X, Ng E, Yip C, Eisterer W, Chalandon Y, Stuible M et al. (2002). Blood 100: 3731-3740.
15. Joung YH, Park JH, Park T, Lee CS, Kim OH, Ye SK et al. (2003). Exp Mol Med 35: 350-357.
16. Liu CB, Itoh T, Arai K, Watanabe S. (1999). J Biol Chem 274: 6342-6349.
17. McCormack MP, Gonda TJ. (1997). Blood 90: 1471-1481.
18. McCubrey JA, Shelton JG, Steelman LS, Franklin RA, Sreevalsan T, McMahon M. (2004). Oncogene 23: 7810-7820.
19. McCubrey JA, Steelman LS, Hoyle PE, Blalock WL, Weinstein-Oppenheimer C, Franklin RA et al. (1998). Leukemia 12: 1903-1929.
20. Morita S, Kojima T, Kitamura T. (2000). Gene Ther 7: 1063-1066.
21. Mui AL, Wakao H, O'Farrell AM, Harada N, Miyajima A. (1995). EMBO J 14: 1166-1175.
22. Nagata Y, Todokoro K. (1996). Biochem Biophys Res Commun 221: 785-789.
23. Nair AP, Diamantis ID, Conscience JF, Kindler V, Hofer P, Moroni C. (1989). Mol Cell Biol 9: 1183-1190.
24. Nosaka T, Kitamura T. (2002). Exp Hematol 30: 697-702.
25. Onishi M, Kinoshita S, Morikawa Y, Shibuya A, Phillips J, Lanier LL et al. (1996a). Exp Hematol 24: 324-329.
26. Onishi M, Mui AL, Morikawa Y, Cho L, Kinoshita S, Nolan GP et al. (1996b). Blood 88: 1399-1406.
27. Onishi M, Nosaka T, Misawa K, Mui AL, Gorman D, McMahon M et al. (1998). Mol Cell Biol 18: 3871-3879.
28. Overell RW, Watson JD, Gallis B, Weisser KE, Cosman D, Widmer MB. (1987). Mol Cell Biol 7: 3394-3401.
29. Perkins GR, Marshall CJ, Collins MK. (1996). Blood 87: 3669-3675.
30. Piao X, Bernstein A. (1996). Blood 87: 3117-3123.
31. Shelton JG, Steelman LS, Lee JT, Knapp SL, Blalock WL, Moye PW et al. (2003). Oncogene 22: 2478-2492.
32. Shounan Y, Miller M, Symonds G. (1995). Exp Hematol 23: 492-499.
33. Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA. (2004). Leukemia 18: 189-218.
34. Stoecklin G, Colombi M, Raineri I, Leuenberger S, Mallaun M, Schmidlin M et al. (2002). EMBO J 21: 4709-4718.
35. Stoecklin G, Gross B, Ming XF, Moroni C. (2003). Oncogene 22: 3554-3561.
36. Stoecklin G, Hahn S, Moroni C. (1994). J Biol Chem 269: 28591-28597.
37. Testa U, Riccioni R, Diverio D, Rossini A, Lo Coco F, Peschle C. (2004). Leukemia 18: 219-226.
38. Wodnar-Filipowicz A, Heusser CH, Moroni C. (1989). Nature 339: 150-152.